UnitedHealth Group has been hit by multiple negative developments over the last week. However, Wall Street remains overwhelmingly bullish about the stock. Few stocks have been as resilient as ...

Few stocks have been as resilient as UnitedHealth Group (NYSE: UNH). The company operates the largest health insurance business in the U.S. It runs the second biggest pharmacy benefits manager (PBM).

The Wall Street Journal reports the DOJ is investigating UnitedHealth Group for possible Medicare fraud. UnitedHealth Group's stock tumbled again on Thursday amid the report. Since last month ...

Shares of UnitedHealth Group plunged more than 13% on Thursday following a report that the Department of Justice is conducting a criminal investigation into the health-care giant over possible ...

The stock price of UnitedHealth Group (NYSE: UNH) is sinking yet again this morning after reports that the private healthcare company is now under criminal investigation by the Department of ...

UnitedHealth Group is being investigated for possible Medicare fraud, according to The Wall Street Journal, sending shares of the healthcare company sliding in after-hours trading just one day ...

UnitedHealth Group, a key Dow-30 index company with a market capitalization of $284 billion, is down 38% year to date and by a similar margin over the last one year. (Shutterstock) UnitedHealth ...

Hemsley was UnitedHealth Group CEO from 2006 to 2017. He will remain chairman of the company’s board. Witty will serve as a senior adviser to Hemsley. It has been a punishing period for ...

Hemsley was UnitedHealth Group CEO from 2006 to 2017. He will remain chairman of the company’s board. Witty will serve as a senior adviser to Hemsley. Musk’s X sues New York over requirement ...

Andrew Witty, UnitedHealth Group's CEO, stepped down for personal reasons, the company announced Tuesday. Stephen Hemsley has been appointed the company's CEO. Meanwhile, UnitedHealth Group has ...

UnitedHealth Group on Tuesday announced the surprise exit of CEO Andrew Witty and suspended its 2025 forecast, sending shares of the health-care giant tumbling more than 10% in morning trading.